| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.060 | Biomarker | phenotype | BEFREE | As almost all patients with high-risk neuroblastomas have autograft, we aimed to determine if minimal residual disease (MRD) quantified by RT-PCR for tyrosine hydroxylase in PBSC is prognostic in neuroblastomas. | 23596146 | 2013 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | We investigated whether detection of minimal residual disease (MRD) in peripheral blood stem cells (PBSC) by using tyrosine hydroxylase (TH) expression could predict outcome of patients with advanced neuroblastoma. | 19125082 | 2009 | ||||
|
0.060 | AlteredExpression | phenotype | LHGDN | We investigated whether detection of minimal residual disease (MRD) in peripheral blood stem cells (PBSC) by using tyrosine hydroxylase (TH) expression could predict outcome of patients with advanced neuroblastoma. | 19125082 | 2009 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | Based on these results, the detection of TH mRNA is very useful both as a tumor marker for NB and for detecting minimal residual disease. | 14993794 | 2004 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | These new splicing variants are described in a region of TH previously reported to be conserved, and that has been used for the design of reverse transcriptase-polymerase chain-reaction assays for the detection of minimal residual disease [Eur.J.Cancer, 27 (1991) 762]. | 12493595 | 2003 | ||||
|
0.060 | AlteredExpression | phenotype | LHGDN | Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma. | 12576454 | 2003 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma. | 12576454 | 2003 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | PGP 9.5 expression should allow sensitive detection of minimal residual disease for ES and pPNET using reverse transcription-PCR, and the variability in TH and PGP 9.5 expression levels in neuroblastomas indicates that expression of both genes should be used for monitoring minimal residual disease by reverse transcription-PCR. | 10690538 | 2000 |